Research Center for Traditional Chinese Medicine Complexity System, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Department of Medical Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Chin J Integr Med. 2022 Jun;28(6):501-508. doi: 10.1007/s11655-021-3279-8. Epub 2021 Jan 9.
To explore the molecular bases of Chinese medicine (CM) syndrome classification in chronic hepatitis B (CHB) patients in terms of DNA methylation, transcription and cytokines.
Genome-wide DNA methylation and 48 serum cytokines were detected in CHB patients (DNA methylation: 15 cases; serum cytokines: 62 cases) with different CM syndromes, including dampness and heat of Gan (Liver) and gallbladder (CHB1, DNA methylation: 5 cases, serum cytokines: 15 cases), Gan stagnation and Pi (Spleen) deficiency (CHB2, DNA methylation: 5 cases, serum cytokines: 15 cases), Gan and Shen (Kidney) yin deficiency (CHB3, DNA methylation: 5 cases, serum cytokines: 16 cases), CHB with hidden symptoms (HS, serum cytokines:16 cases) and healthy controls (DNA methylation: 6 cases). DNA methylation of a critical gene was further validated and its mRNA expression was detected on enlarged samples. Genome-wide DNA methylation was detected using Human Methylation 450K Assay and furthered verified using pyrosequencing. Cytokines and mRNA expression of gene were evaluated using multiplex biometric enzyme-linked immunosorbent assay (ELISA)-based immunoassay and reverse transcription-quantitative polymerase chain reaction (RT-qPCR), respectively.
Totally 28,667 loci, covering 18,403 genes were differently methylated among CHB1, CHB2 and CHB3 (P<0.05 and |Δβ value| > 0.17). Further validation showed that compared with HS, the hg19 CHR6: 29691140 and its closely surrounded 2 CpG loci were demethylated and its mRNA expressions were significantly up-regulated in CHB1 (P<0.05). However, they remained unaltered in CHB2 (P>0.05). Levels of Interleukin (IL)-12 were higher in CHB3 and HS than that in CHB1 and CHB2 groups (P<0.05). Levels of macrophage inflammatory protein (MIP)-1α and MIP-1β were higher in CHB3 than other groups and leukemia inhibitory factor level was higher in CHB1 and HS than CHB2 and CHB3 groups (P<0.05). IL-12, MIP-1α and MIP-1β concentrations were positively correlated with human leukocyte antigen F (HLA-F) mRNA expression (R=0.238, P<0.05; R=0.224, P<0.05; R=0.447, P<0.01; respectively). Furthermore, combination of HLA-F mRNA and differential cytokines greatly improved the differentiating accuracy among CHB1, CHB2 and HS.
Demethylation of CpG loci in 5' UTR of HLA-F may up-regulate its mRNA expression and HLA-F expression was associated with IL-12, MIP-1α and MIP-1β levels, indicating that HLA-F and the differential cytokines might jointly involve in the classification of CM syndromes in CHB.
ChiCTR-RCS-13004001.
从 DNA 甲基化、转录和细胞因子角度探讨慢性乙型肝炎(CHB)患者中医证候分类的分子基础。
对不同中医证候(包括肝胆湿热证、肝郁脾虚证、肝肾阴虚证、隐匿性乙型肝炎和健康对照)的 CHB 患者(DNA 甲基化:15 例;血清细胞因子:62 例)进行全基因组 DNA 甲基化和 48 种血清细胞因子检测。DNA 甲基化采用 Human Methylation 450K 检测,进一步采用焦磷酸测序验证;细胞因子和基因的 mRNA 表达采用基于多重生物标志物酶联免疫吸附测定(ELISA)的免疫分析和逆转录定量聚合酶链反应(RT-qPCR)进行评估。
CHB1、CHB2 和 CHB3 之间有 28667 个差异甲基化基因(P<0.05,|Δβ 值| > 0.17)。进一步验证表明,与 HS 相比,CHB1 中 hg19 CHR6:29691140 及其附近的 2 个 CpG 位点呈去甲基化,mRNA 表达显著上调(P<0.05),而在 CHB2 中则无变化(P>0.05)。CHB3 和 HS 组的白细胞介素(IL)-12 水平高于 CHB1 和 CHB2 组(P<0.05)。CHB3 组巨噬细胞炎性蛋白(MIP)-1α 和 MIP-1β 水平高于其他组,CHB1 和 HS 组白血病抑制因子水平高于 CHB2 和 CHB3 组(P<0.05)。IL-12、MIP-1α 和 MIP-1β 浓度与人类白细胞抗原 F(HLA-F)mRNA 表达呈正相关(R=0.238,P<0.05;R=0.224,P<0.05;R=0.447,P<0.01;分别)。此外,HLA-F mRNA 和差异细胞因子的联合极大地提高了 CHB1、CHB2 和 HS 之间的鉴别准确性。
HLA-F 5'UTR 中 CpG 位点的去甲基化可能上调其 mRNA 表达,而 HLA-F 的表达与 IL-12、MIP-1α 和 MIP-1β 水平相关,提示 HLA-F 和差异细胞因子可能共同参与 CHB 中医证候的分类。
ChiCTR-RCS-13004001。